Septerna, Inc.

SEPN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023
Assets
Cash & Equivalents $120.7M $238.2M $88.5M
Accounts Receivable $10.4M $171.0K $151.0K
Inventory — — —
Total Current Assets $411.0M $356.8M $112.7M
Property, Plant & Equipment $4.4M $5.1M $4.7M
Goodwill — — —
Intangible Assets (Excl. Goodwill) — — —
Total Assets $596.2M $456.6M $130.9M
Liabilities
Accounts Payable $10.3M $3.2M $2.6M
Total Current Liabilities $86.9M $12.8M $6.9M
Long-Term Debt — — —
Total Liabilities $214.3M $36.5M $20.0M
Stockholders' Equity
Retained Earnings $-167.3M $-118.4M $-46.6M
Total Stockholders' Equity $381.9M $420.0M $-38.4M